Sign In
Buy ISR
$0.384
+0 (+0%)
At Close: May 16, 2023
Uranium Energy Corp Advances South Texas Portfolio with Increased Resources at the Burke Hollow ISR Project
06:30am, Thursday, 13'th Jun 2024
NYSE American: UEC Following a successful delineation drilling program since the last resource update on August 12, 2022, a new S-K 1300 technical report summary (the "TRS") increases the Burke Hollo
Denison Announces Completion of Inaugural ISR Field Test Program at Midwest
06:30am, Monday, 03'rd Jun 2024
TORONTO , June 3, 2024 /PRNewswire/ - Denison Mines Corp. ("Denison") (TSX: DML) (NYSE American: DNN) is pleased to announce it has completed the inaugural In-Situ Recovery ("ISR") field test progr
BAE Systems awarded U.S. Navy contract to continue supporting Mobile Deployable C5ISR programs
01:00pm, Thursday, 14'th Mar 2024
MCLEAN, Va. , March 14, 2024 /PRNewswire/ -- The U.S. Navy has awarded BAE Systems (LON: BA) a contract worth approximately $86 million to continue supporting its Mobile Deployable Command, Control,
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
06:49pm, Thursday, 16'th Feb 2023
IsoRay (ISR) delivered earnings and revenue surprises of -100% and 56.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
enCore Energy closes acquisition of Alta Mesa In-Situ Recovery uranium project
07:26am, Wednesday, 15'th Feb 2023
enCore Energy Corp (TSX-V:EU, NYSE-A:EU) said it has completed its acquisition of the Alta Mesa In-Situ Recovery uranium project from Energy Fuels Inc. The transaction provides enCore with three licen
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
06:55pm, Thursday, 10'th Nov 2022
Isoray, Inc. (NYSE:ISR ) Q1 2023 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Thijs Spoor - CEO, Viewpoint Molecular Targeting Jonathan H
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
08:14am, Monday, 31'st Oct 2022
Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
04:30pm, Tuesday, 18'th Oct 2022
RICHLAND, Wash.
Isoray, Inc. (ISR) Q4 2022 Earnings Call Transcript
10:35pm, Wednesday, 28'th Sep 2022
Isoray, Inc. (NYSE:ISR ) Q4 2022 Earnings Conference Call September 28, 2022 4:30 PM ET Company Participants Mark Levin - Investor Relations Lori Woods - Chief Executive Officer Thijs Spoor - Chief Ex
IsoRay (ISR) Reports Q4 Loss, Misses Revenue Estimates
06:49pm, Wednesday, 28'th Sep 2022
IsoRay (ISR) delivered earnings and revenue surprises of 0% and 13.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022
08:13am, Wednesday, 21'st Sep 2022
Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT
IsoRay (ISR) Reports Q3 Loss, Lags Revenue Estimates
10:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
IsoRay (ISR) delivered earnings and revenue surprises of 0% and 7.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Oncternal Therapeutics (ONCT) Reports Q1 Loss, Tops Revenue Estimates
09:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of -5.26% and 6.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022
08:05am, Friday, 29'th Apr 2022
Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference
01:13pm, Thursday, 10'th Mar 2022 GlobeNewswire
RICHLAND, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy, today announced that Chief Executive Officer Lori Woods will participate in a virtual fireside chat at the Oppenheimer 32 nd Annual Healthcare Conference on Thursday, March 17 at 1:20 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.
